MedTrace Logo

Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer

NCT01190657 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1184

Last updated 2013-04-01

No results posted yet for this study

Summary

This is a self-controlled, open, multiple-center clinical trial.

Conditions

  • Acute Gastritis
  • Gastric Ulcer

Interventions

DRUG

Selbex

50mg/day, 3 times/day, for 14 days

DRUG

Selbex

50mg/day, 3 times/day, for 56 days

Sponsors & Collaborators

  • Eisai Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yaozong Yuan · Ruijin Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01190657 on ClinicalTrials.gov